- Filed
- Nov 18, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Nov 13, 2024 | 36.8M sh |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $2.11M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $1.62M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $2.11M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $1.67M |
| Current Assets | Q3 2024 · Sep 30, 2024 | $1.11M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $1.22M |
| Total Assets | Q3 2024 · Sep 30, 2024 | $4.95M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $5.3M |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 97.55M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 96.37M sh |
| Capex | Q3 2024 · Sep 30, 2023 | $2.23K |
| Operating Cash Flow | Q3 2024 · Sep 30, 2023 | −$819.94K |
| Stockholders Equity restated | Q3 2024 · Sep 30, 2023 | $3.32M |
| Stockholders Equity restated | Q3 2024 · Jun 30, 2023 | $2.84M |
| Stockholders Equity restated | Q3 2024 · Mar 31, 2023 | $3.02M |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | $3.35M |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | −$0.09 |
| Eps Diluted | Q3 2024 · Sep 30, 2023 | −$0.10 |
| Sga Expense restated | Q3 2024 · Sep 30, 2023 | $87.53K |
| Sga Expense restated | Q3 2024 · Sep 30, 2023 | $239.21K |
| Net Income restated | Q3 2024 · Sep 30, 2023 | −$9.08M |
| Net Income restated | Q3 2024 · Sep 30, 2023 | −$9.92M |
| Net Income restated | Q3 2024 · Jun 30, 2023 | −$417.87K |
| Net Income restated | Q3 2024 · Mar 31, 2023 | −$415.42K |
| Operating Income restated | Q3 2024 · Sep 30, 2023 | −$9.08M |
| Operating Income restated | Q3 2024 · Sep 30, 2023 | −$9.92M |
| Revenue | Q3 2024 · Sep 30, 2023 | $174.71K |
| Revenue | Q3 2024 · Sep 30, 2023 | $258.66K |